CERS vs PODD · rev $201.3M vs P/E 34, rev $2.07B
Cerus Corporation (CERS) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CERS currently screens at market cap $294.4M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CERS and PODD stock pages for the full models.
Not investment advice.